JGGDR
SMMT icon

JGP Global Gestao de Recursos’s Summit Therapeutics SMMT Stock Holding History

JGP Global Gestao de Recursos’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,868
Closed -$266K – 54
2025
Q3 		$266K Sell
12,868
-2,498
-16% -$60.6K 0.15% 26
2025
Q2 		$327K Hold
15,366
– – 0.16% 29
2025
Q1 		$296K Sell
15,366
-1,714
-10% -$34.4K 0.23% 24
2024
Q4 		$305K Hold
17,080
– – 0.69% 30
2024
Q3 		$374K Buy
+17,080
New +$239K 0.73% 25

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
PCMH
Polymer Capital Management (HK) Hong Kong $1.98B AUM 210.13% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

JGP Global Gestao de Recursos's SMMT Position: Q4 2025 in Review

JGP Global Gestao de Recursos sold out of Summit Therapeutics (SMMT) in Q4 2025, closing a stake of 12,868 shares — an estimated $266K sold.

JGP Global Gestao de Recursos first reported a position in SMMT in Q3 2024 and held it in 5 quarters. The position peaked at $374K in Q3 2024. 206 funds tracked by Wall St. Rank hold SMMT as of Q4 2025.

  • JGP Global Gestao de Recursos reported no remaining Summit Therapeutics position as of Q4 2025 after selling out during the quarter.
  • JGP Global Gestao de Recursos sold 12,868 Summit Therapeutics shares in Q4 2025, an estimated $266K.
  • JGP Global Gestao de Recursos first reported a position in Summit Therapeutics in Q3 2024 and held it in 5 quarters.
  • JGP Global Gestao de Recursos's Summit Therapeutics position peaked at $374K in Q3 2024.
  • 206 funds tracked by Wall St. Rank held Summit Therapeutics as of Q4 2025.

Based on JGP Global Gestao de Recursos's 13F filing for Q4 2025, filed 26 Jan 2026.